FDA PrEPares to reduce risk of HIV infection with Truvada®.
作者信息
Breeze Sophie
出版信息
Expert Rev Clin Pharmacol. 2012 Sep;5(5):499.
PMID:23272332
Abstract
摘要
相似文献
1
FDA PrEPares to reduce risk of HIV infection with Truvada®.
Expert Rev Clin Pharmacol. 2012 Sep;5(5):499.
2
Transmission. Company halts Truvada PrEP for women study.
AIDS Policy Law. 2011 Jun;26(7):1.
3
FDA approves first drug to prevent HIV infection.
BMJ. 2012 Jul 17;345:e4879. doi: 10.1136/bmj.e4879.
4
AIDS research. FDA panel recommends anti-HIV drug for prevention.
Science. 2012 May 18;336(6083):792. doi: 10.1126/science.336.6083.792.
5
Generic Truvada approved.
AIDS Patient Care STDS. 2009 May;23(5):395.
6
HIV drug-prevention strategy carries risks.
Nature. 2011 Aug 16;476(7360):260-1. doi: 10.1038/476260a.
7
HIV pre-exposure prophylaxis.
BMJ. 2012 Aug 13;345:e5412. doi: 10.1136/bmj.e5412.
8
Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
Am Fam Physician. 2013 Oct 15;88(8):535-40.
9
Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa.
10
Truvada and Epivir are similar at suppressing HIV.
Proj Inf Perspect. 2009 Mar(48):5-6.
Zotero 插件